Cutaneous Rosai-Dorfman disease: Remission with thalidomide treatment [2]

British Journal of Dermatology

Volumn 148, Issue 5, 2003, Pages 1060-1061

  Tjiu, J W ^a   Hsiao, C H ^a   Tsai, T F ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; DAPSONE; HYDROXYCHLOROQUINE SULFATE; PREDNISONE; PROTEIN S 100; THALIDOMIDE;

ADULT; CASE REPORT; CLINICAL EXAMINATION; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; PRIORITY JOURNAL; ROSAI DORFMAN DISEASE; SKIN BIOPSY;

FACIAL DERMATOSES; FEMALE; HISTIOCYTOSIS, SINUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; THALIDOMIDE;

EID: 0037863042     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2003.05311.x     Document Type: Letter

References (11)

1. Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy: a newly recognized benign clinicopathological entity. Arch Pathol 1969; 87: 63-70.
2. Thawerani H, Sanchez RL, Rosai J et al. The cutaneous manifestation of histiocytosis with massive lymphadenopathy. Arch Dermatol 1978; 114: 191-7.
3. Annessi G, Giannetti A. Purely cutaneous Rosai-Dorfman disease. Br J Dermatol 1996; 134: 749-53.
4. Salim A, Williamson M, Barker F et al. Steroid responsive cutaneous Rosai-Dorfman disease associated with uveitis and hypothyroidism. Clin Exp Dermatol 2002; 27: 277-9.
5. Tseng S, Pak G, Washenik K et al. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol 1996; 35: 969-79.
6. Viraben R, Dupre A, Gorguet B. Pure cutaneous histiocytosis resembling sinus histiocytosis. Clin Exp Dermatol 1988; 13: 197-9.
7. Silvestre JF, Aliaga A. Cutaneous sinus histiocytosis and chronic uveitis. Pediatr Dermatol 2000; 17: 377-80.
8. Ordi J, Cortes F, Martinez N et al. Thalidomide induces amenorrhea in patients with lupus disease. Arthritis Rheum 1998; 41: 2273-5.
9. Ordi-Ros J, Cortés F, Cucurull E et al. Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol 2000; 27: 1429-33.
10. Passeron T, Lacour J-P, Murr D et al. Thalidomide-induced amenorrhoea: two cases. Br J Dermatol 2001; 144: 1292-3.
11. Gompel A, Frances C, Piette JC et al. Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al. Arthritis Rheum 1999; 42: 2259-60.